Shreya joined Quikart in 2014 as a back-end engineer at a salary roughly 30% below market. The offer letter said "₹X cash + ESOPs". She signed without reading the stock-option annexure. Twelve months later she got a "Grant Letter" with 8,000 options at a strike price of ₹100. Five years of vesting. She stuck it out, the company became a unicorn, the strike was a fraction of the FMV. In 2025, a buyer tendered for 30% of the company at ₹17,500 per share. Shreya tendered all her options.
Net incoming wire: not ₹14 crore. After three deductions she didn't know were coming, it was ₹8.84 crore. ₹5.16 crore went to the Indian tax department across two different financial years.
Most of which she could have planned around. None of which her HR explained.
- ESOPs in India hit you at two of the four lifecycle events: exercise (perquisite tax under Sec 17(2)(vi)) and sale (capital gains under Sec 49(2AA) + Sec 112A or relevant section).
- At exercise: (FMV on exercise date − exercise price) × shares = perquisite. Taxed at your slab rate. Employer withholds via TDS Sec 192. This is the painful one — you pay tax on paper gains, in cash, before you've sold anything.
- At sale: (sale price − FMV on exercise date) × shares = capital gain. STCG/LTCG rates apply based on holding period from exercise date. Post 23 Jul 2024: listed equity STCG 20%, LTCG 12.5% above ₹1.25L; unlisted 12.5% no indexation.
- Startups DPIIT-recognised under Sec 80-IAC get a 5-year deferral on the perquisite tax (Sec 192(1C)). Most others don't.
- The single biggest mistake: exercising at the highest FMV, paying perq tax in cash, then watching the share price drop. You owe tax even if the shares later become worthless. Plan the exercise timing carefully.
The four events — what fires when
You receive a Grant Letter. The company allots you, say, 8,000 options at a ₹100 strike, vesting over 5 years. Nothing is taxable. You don't even own shares yet — just the right to buy them at a fixed price after vesting.
Each year (or quarter, depending on schedule), a portion vests — you become eligible to exercise it. Still no tax. The Indian system, unlike the US, does NOT tax at vest.
You pay the strike price (₹100 × shares) and the company issues you actual shares. At this moment, the difference between the FMV on the exercise date and the strike price is treated as a salary perquisite under Sec 17(2)(vi). Employer withholds TDS at your slab rate from your regular salary (typically over the next 2-3 months) or asks you to bring the cash to pay it.
Example: 8,000 options at ₹100 strike. FMV on exercise day: ₹17,500 (per a recent funding round / 409A). Perquisite = (17,500 − 100) × 8,000 = ₹13.92 crore. At 30%+ slab + cess + surcharge: roughly ₹4.85 crore tax due — even though Shreya hasn't sold a share.
Whenever you later sell, the cost of acquisition is the FMV that was already taxed at exercise (Sec 49(2AA)). So you don't get taxed on the same amount twice.
Capital gain = sale price − FMV-at-exercise. Period of holding starts from exercise date.
The compare card you should print and stick on your monitor
Sec 17(2)(vi) — Exercise
Perquisite, slab rate
(FMV on exercise − strike) × shares. Added to salary. Taxed at slab + surcharge + cess. TDS withheld by employer under Sec 192. Surcharge in old regime: 10% >₹50L, 15% >₹1cr, 25% >₹2cr, 37% >₹5cr (new regime caps at 25%).
Sec 49(2AA) — Sale
Capital gains
Cost of acquisition = FMV at exercise (not strike). Period of holding starts at exercise date. Listed equity: STCG 20% / LTCG 12.5% >₹1.25L (Sec 111A / 112A). Unlisted (most startups): STCG slab / LTCG 12.5% no indexation.
Shreya's actual numbers
- Options granted: 8,000 @ strike ₹100 (2014)
- Fully vested by: 2019
- Exercise date: April 2025. FMV on date: ₹17,500/share. Perquisite = ₹13.92cr. Tax @ ~35% effective (after surcharge): ~₹4.85cr. TDS deducted by employer over 3 months from salary; she put in additional self-assessment tax.
- Sale date: June 2025 (held 2 months from exercise → STCG)
- Sale price: ₹17,500/share = ₹14cr. Capital gain = (17,500 − 17,500) × 8,000 = ₹0 (because exercise FMV = sale price). No CG tax.
- Net to bank: ₹14cr − ₹4.85cr (perq tax) − strike already paid ₹8L = ~₹8.84cr
The painful insight: nearly all of Shreya's tax was the perquisite tax at exercise, not the capital gains tax at sale. Because she exercised right before the tender at the same valuation, her capital gain was ₹0. If she had exercised when FMV was lower (say, ₹8,000 from a previous funding round) and held the shares, she'd have:
- Lower perq tax at exercise: ₹6.32cr perquisite × 35% = ₹2.21cr
- Higher capital gain at sale: (17,500 − 8,000) × 8,000 = ₹7.6cr
- If held >24 months from exercise: LTCG 12.5% on ₹7.6cr = ₹95L
- Total tax: ₹2.21cr + ₹95L = ₹3.16cr — saving of ₹1.69cr
This is the planning lever that disappears the moment you exercise. Once exercise FMV equals sale FMV, the structural advantage of LTCG rates over slab rates evaporates.
If you have vested options and the company is private with no liquidity event in sight, exercising early at a low FMV can be powerful — you fix the perq base at today's low FMV, and any future appreciation flows to capital gains at lower rates. But — you pay perq tax now, on a stock you can't sell. If the company fails, that tax money is gone forever. Trade-off requires belief, not just math.
The DPIIT startup deferral (Sec 192(1C))
Finance Act 2020 added a relief for employees of DPIIT-recognised eligible startups under Sec 80-IAC: the perquisite tax at exercise can be deferred for up to 5 years, or until the earliest of:
- 5 years from end of relevant FY, OR
- Date of sale of shares, OR
- Date employee ceases to be employed with the company
This is genuinely useful — it converts the "pay tax on paper gains in cash" problem into "pay tax when you can actually sell". The catch: only eligible startups (must be DPIIT-recognised + Sec 80-IAC-eligible) get to offer this. Most established unicorns are well past the 10-year eligibility window.
Foreign-employer ESOPs / RSUs (US parent, Indian employee)
If you work for the Indian arm of a US parent and receive RSUs of the US listed parent, the rules apply identically in spirit but with two wrinkles:
- RSUs are taxed at vest (not exercise), because there's no "exercise" — the share is transferred to you on vest. Perquisite = FMV at vest × shares. Slab rate.
- Sale of foreign shares: foreign capital gains. Taxable in India for Resident-OR. Sale via US brokerage. Foreign Tax Credit via Form 67 if US withheld tax. Schedule FA disclosure mandatory (₹10L penalty for non-disclosure).
For Indian listed equities + ESOP, this is simpler — STT paid → Sec 111A / 112A rates apply. Read our capital gains guide for the rate matrix.
The four-event tax dance — quick action checklist
- At grant: file the grant letter. No action.
- At vest: no action (Indian rules). Track the vesting calendar so you don't lose track of how many vested options you hold.
- At exercise:
- Get the FMV certificate (from a SEBI-registered merchant banker for unlisted shares; market price for listed).
- Pay strike price.
- Calculate perq = (FMV − strike) × shares.
- Employer should deduct TDS via salary; verify in payslip + Form 16.
- If TDS is short of slab rate, pay self-assessment in advance-tax instalments (Q1-Q4) to avoid Sec 234C interest.
- At sale:
- Cost of acquisition = FMV at exercise (per Sec 49(2AA)).
- Period of holding = sale date − exercise date.
- Apply STCG/LTCG rates based on listing status + holding period.
- Report under Schedule CG in ITR-2 / ITR-3.
The funny historical wrinkle
For years, Indian tax law had no special treatment for ESOPs at all — they were taxed as "perquisite" the moment shares were allotted (vest = exercise in the old days), at full slab rate, regardless of whether the employee could realise any cash. This pushed startups offshore in the 2000s and 2010s — many promising companies incorporated in Delaware or Singapore specifically so their Indian engineers could get US-style stock-options taxed only at sale.
The DPIIT recognition + Sec 192(1C) deferral (added 2020) and the gradual harmonisation of capital gains rules has narrowed this gap. Indian-domiciled startups can now offer ESOPs that don't bankrupt their early engineers at exercise. The gap with US "qualified ISO" treatment is still there, but smaller.
Quick answers
Only if there's liquidity. For a listed company, yes — "cashless exercise" where some shares are sold the same day to cover the perquisite tax is standard. For an unlisted startup with no tender offer or buyback, you have to bring outside cash. Many early employees take personal loans to exercise; risky if the company stalls.
Practically, no. You can spread the exercise across multiple FYs to manage surcharge bracket-creep, but the perquisite tax itself is unavoidable at exercise. Strong reason to ask in offer-letter discussions whether the company will help with a loan or buyback to fund the tax.
Yes — capital loss on eventual sale. But it doesn't refund the perquisite tax already paid. The capital loss can be set off against other capital gains (STCG against STCG/LTCG; LTCG only against LTCG) and carried forward 8 years. Cold comfort but real.
RSUs: taxed as perquisite at vest (no exercise step). ESOPs: taxed as perquisite at exercise. Capital gains math at eventual sale is the same. Cost of acquisition = FMV taxed at vest (RSU) or at exercise (ESOP).
Same rules — sale = capital gain. For unlisted shares: STCG (≤24 months) at slab, LTCG (>24 months) at 12.5% without indexation. Tender-offer or secondary-purchase doesn't change the section, just the buyer.
When you might want help
Three situations: (1) You've been granted options at an early-stage startup and want a baseline plan for exercise timing. (2) Your company has announced a tender / secondary / IPO and you have 30-60 days to decide what to do. (3) You've just exercised — quarterly advance-tax planning so you don't get Sec 234C interest on top.
Sitting on vested options?
We map your full ESOP lifecycle — exercise timing, FMV verification, advance-tax plan, capital-gains-at-sale projection. Fixed scope, fixed fee.
"Shreya" and "Quikart" are composite illustrations drawn from publicly known features of Indian unicorn ESOP tender events. No specific company or individual is intended.